Search for other papers by Ida Staby in
Google Scholar
PubMed
Search for other papers by Jesper Krogh in
Google Scholar
PubMed
Search for other papers by Marianne Klose in
Google Scholar
PubMed
Search for other papers by Jonas Baekdal in
Google Scholar
PubMed
Department of Clinical Medicine, Faculty of Health and Clinical Sciences, Copenhagen University, Copenhagen, Denmark
Search for other papers by Ulla Feldt-Rasmussen in
Google Scholar
PubMed
Search for other papers by Lars Poulsgaard in
Google Scholar
PubMed
Search for other papers by Jacob Bertram Springborg in
Google Scholar
PubMed
Department of Clinical Medicine, Faculty of Health and Clinical Sciences, Copenhagen University, Copenhagen, Denmark
Search for other papers by Mikkel Andreassen in
Google Scholar
PubMed
/oligomenorrhoea for premenopausal women. A diagnosis of Cushing’s disease or acromegaly was established according to the standard criteria. We did not report on GH deficiency or anti-diuretic hormone insufficiency because only a few patients were examined with GH
Search for other papers by Jose M Garcia in
Google Scholar
PubMed
Search for other papers by Beverly M K Biller in
Google Scholar
PubMed
Search for other papers by Márta Korbonits in
Google Scholar
PubMed
Search for other papers by Vera Popovic in
Google Scholar
PubMed
Search for other papers by Anton Luger in
Google Scholar
PubMed
Search for other papers by Christian J Strasburger in
Google Scholar
PubMed
Search for other papers by Philippe Chanson in
Google Scholar
PubMed
Search for other papers by Ronald Swerdloff in
Google Scholar
PubMed
Search for other papers by Christina Wang in
Google Scholar
PubMed
Search for other papers by Rosa Rosanna Fleming in
Google Scholar
PubMed
Search for other papers by Fredric Cohen in
Google Scholar
PubMed
Search for other papers by Nicola Ammer in
Google Scholar
PubMed
Search for other papers by Gilbert Mueller in
Google Scholar
PubMed
Search for other papers by Nicky Kelepouris in
Google Scholar
PubMed
Search for other papers by Frank Strobl in
Google Scholar
PubMed
Search for other papers by Vlady Ostrow in
Google Scholar
PubMed
Search for other papers by Kevin C J Yuen in
Google Scholar
PubMed
data indicate that for the oral glucose tolerance test, BMI, sex, and use of oral contraceptives containing estradiol can significantly affect GH nadir levels, suggesting that the GH cutpoints used to diagnose acromegaly with this test may need to be
Search for other papers by Jintao Hu in
Google Scholar
PubMed
Search for other papers by Qingbo Chen in
Google Scholar
PubMed
Search for other papers by Xiao Ding in
Google Scholar
PubMed
Search for other papers by Xin Zheng in
Google Scholar
PubMed
Search for other papers by Xuefeng Tang in
Google Scholar
PubMed
Search for other papers by Song Li in
Google Scholar
PubMed
Search for other papers by Hui Yang in
Google Scholar
PubMed
Background Pituitary adenoma (PA) is the second most common brain tumor. Except for prolactinoma, pituitary tumors associated with acromegaly (growth hormone-secreting) and Cushing’s disease (adrenocorticotropic hormone-secreting) as well as
Search for other papers by Mark R Postma in
Google Scholar
PubMed
Search for other papers by Pia Burman in
Google Scholar
PubMed
Search for other papers by André P van Beek in
Google Scholar
PubMed
patients with a previous diagnosis of Cushing’s disease, acromegaly and craniopharyngioma because these conditions are known to affect body composition, cardiovascular risk factors and quality of life. For similar reasons of confounding bias, females
Centre for Person-Centred Care (GPCC), University of Gothenburg, Gothenburg, Sweden
Department of Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden
Search for other papers by Eva Jakobsson Ung in
Google Scholar
PubMed
Search for other papers by Ann-Charlotte Olofsson in
Google Scholar
PubMed
Centre for Person-Centred Care (GPCC), University of Gothenburg, Gothenburg, Sweden
Search for other papers by Ida Björkman in
Google Scholar
PubMed
Institute of Neuroscience and Physiology, University of Gothenburg, Sahlgrenska Academy, Gothenburg, Sweden
Search for other papers by Tobias Hallén in
Google Scholar
PubMed
Department of Internal Medicine and Clinical Nutrition, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
Search for other papers by Daniel S Olsson in
Google Scholar
PubMed
Department of Internal Medicine and Clinical Nutrition, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
Search for other papers by Oskar Ragnarsson in
Google Scholar
PubMed
Institute of Neuroscience and Physiology, University of Gothenburg, Sahlgrenska Academy, Gothenburg, Sweden
Search for other papers by Thomas Skoglund in
Google Scholar
PubMed
Centre for Person-Centred Care (GPCC), University of Gothenburg, Gothenburg, Sweden
Search for other papers by Sofie Jakobsson in
Google Scholar
PubMed
Department of Internal Medicine and Clinical Nutrition, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
Search for other papers by Gudmundur Johannsson in
Google Scholar
PubMed
a 2 Other lesions in the pituitary b 4 Invasiveness (para sellar) 10 Surgical treatment Primary surgery, TS/TC 16/0 Re-surgery, TS/TC 2/1 a One patient with acromegaly and one with Cushing
Search for other papers by María L Bacigalupo in
Google Scholar
PubMed
Search for other papers by Verónica G Piazza in
Google Scholar
PubMed
Search for other papers by Nadia S Cicconi in
Google Scholar
PubMed
Search for other papers by Pablo Carabias in
Google Scholar
PubMed
Search for other papers by Andrzej Bartke in
Google Scholar
PubMed
Search for other papers by Yimin Fang in
Google Scholar
PubMed
Search for other papers by Ana I Sotelo in
Google Scholar
PubMed
Search for other papers by Gabriel A Rabinovich in
Google Scholar
PubMed
Search for other papers by María F Troncoso in
Google Scholar
PubMed
Search for other papers by Johanna G Miquet in
Google Scholar
PubMed
R Grottoli S Losa M Cannavo S , et al . Acromegaly is associated with increased cancer risk: a survey in Italy . Endocrine-Related Cancer 2017 24 . ( https://doi.org/10.1530/ERC-16-0553 ) 10 Bugni JM Poole TM Drinkwater NR
Search for other papers by Yang Lv in
Google Scholar
PubMed
Search for other papers by Xu Han in
Google Scholar
PubMed
Search for other papers by Chunyan Zhang in
Google Scholar
PubMed
Search for other papers by Yuan Fang in
Google Scholar
PubMed
Search for other papers by Ning Pu in
Google Scholar
PubMed
Search for other papers by Yuan Ji in
Google Scholar
PubMed
Search for other papers by Dansong Wang in
Google Scholar
PubMed
Search for other papers by Xu Xuefeng in
Google Scholar
PubMed
Search for other papers by Wenhui Lou in
Google Scholar
PubMed
octreotide suppression test in predicting long-term responses to depot somatostatin analogues in patients with active acromegaly . Clinical Endocrinology 2005 62 282 – 288 . ( https://doi.org/10.1111/j.1365-2265.2004.02191.x ) 10.1111/j.1365
Search for other papers by Hélène Singeisen in
Google Scholar
PubMed
Search for other papers by Mariko Melanie Renzulli in
Google Scholar
PubMed
Search for other papers by Vojtech Pavlicek in
Google Scholar
PubMed
Search for other papers by Pascal Probst in
Google Scholar
PubMed
Search for other papers by Fabian Hauswirth in
Google Scholar
PubMed
Search for other papers by Markus K Muller in
Google Scholar
PubMed
Search for other papers by Magdalene Adamczyk in
Google Scholar
PubMed
Search for other papers by Achim Weber in
Google Scholar
PubMed
Search for other papers by Reto Martin Kaderli in
Google Scholar
PubMed
Search for other papers by Pietro Renzulli in
Google Scholar
PubMed
M Guerra A Buratto M Foschini MP Tagliati F degli Uberti E Early onset acromegaly associated with a novel deletion in CDKN1B 5'UTR region . Endocrine 2015 49 58 – 64 . ( https://doi.org/10.1007/s12020-015-0540-y ) 42 Borsari S Pardi
Search for other papers by Alessandro Brancatella in
Google Scholar
PubMed
Search for other papers by Claudio Marcocci in
Google Scholar
PubMed
of fracture, independently from BMD ( 36 , 37 ), as often seen in some endocrine disorders, namely acromegaly, Cushing’s disease, hyperparathyroidism and hyperthyroidism ( 38 , 39 , 40 ). Another classical example is glucocorticoid
Search for other papers by Yu Lin in
Google Scholar
PubMed
Search for other papers by Yingying Zhang in
Google Scholar
PubMed
Search for other papers by Lei Xu in
Google Scholar
PubMed
Search for other papers by Wei Long in
Google Scholar
PubMed
Search for other papers by Chunjian Shan in
Google Scholar
PubMed
Search for other papers by Hongjuan Ding in
Google Scholar
PubMed
Search for other papers by Lianghui You in
Google Scholar
PubMed
Search for other papers by Chun Zhao in
Google Scholar
PubMed
Search for other papers by Zhonghua Shi in
Google Scholar
PubMed
, pheochromocytoma, acromegaly, history of smoking, chemical dependency, use of assisted reproductive technology, multiple gestation, and any other confounding pathologies, including hyperthyroidism and hypothyroidism. The exclusion criteria for infants were as